$ファルヴァリス(PHVS.US)$Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week. $アムジェン(AMGN.US)$Inc. is in advanced talks to buy drug company$Horizon Therapeutics(HZNP.US)$, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. $ROCHESTER RESOURCES LTD(RCTFF.US)$Holding AG presented new data from a ...
ファルヴァリスに関するコメント
コラムWeekly FDA Drug Pipeline Calendar (Dec 12 - Dec 17)
$アムジェン(AMGN.US)$ Inc. is in advanced talks to buy drug company $Horizon Therapeutics(HZNP.US)$, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year.
$ROCHESTER RESOURCES LTD(RCTFF.US)$Holding AG presented new data from a ...
Halt down here
まだコメントはありません